Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies

Clinical trial NCT04447027 · COMPLETED

Trial details

NCT number: NCT04447027
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cutaneous T-Cell Lymphoma Mature T-cell Malignancies Peripheral T-Cell Lymphoma Relapsed/ Refractory T-cell Malignancies

Start date: 2020-12-17
Primary completion: 2024-07-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.